Another good reason to consider surgical treatment for epilepsy more often and sooner

Archives of Neurology

Volumn 68, Issue 6, 2011, Pages 707-708

  Engel Jr , Jerome ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; EDITORIAL; EPILEPSY; HUMAN; INTRACTABLE EPILEPSY; MORBIDITY; MORTALITY; NEUROIMAGING; NEUROSURGERY; PATIENT SAFETY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TEMPORAL LOBE EPILEPSY; THREE DIMENSIONAL IMAGING; TREATMENT INDICATION;

ANTERIOR TEMPORAL LOBECTOMY; ANTICONVULSANTS; COMORBIDITY; EPILEPSY, TEMPORAL LOBE; HUMANS; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; TREATMENT FAILURE;

EID: 79958724643     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.113     Document Type: Editorial

References (17)

1. Hauser WA, Hesdorffer DC. Epilepsy: Frequency, Causes and Consequences. New York, NY: Demos Press; 1990.
2. Kwan P, Sander JW. The natural history of epilepsy: an epidemiological view. J Neurol Neurosurg Psychiatry. 2004;75(10):1376-1381. (Pubitemid 39279801)
3. Swarztrauber K, Dewar S, Engel J Jr. Patient attitudes about treatments for intractable epilepsy. Epilepsy Behav. 2003;4(1):19-25. (Pubitemid 36546449)
4. Gilliam FG, Albertson B. Identifying epilepsy surgery candidates in the outpatient clinic. Epilepsy Behav. 2011;20(2):156-159.
5. Engel J Jr. The emergence of neurosurgical approaches to the treatment of epilepsy. In: Waxman S, ed. From Neuroscience to Neurology: Neuroscience, Molecular Medicine, and the Therapeutic Transformation of Neurology. Amsterdam, the Netherlands: Elsevier; 2005:81-105.
6. Semah F, Picot M-C, Adam C, et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology. 1998;51(5):1256-1262. (Pubitemid 28520540)
7. Wiebe S, Blume WT, Girvin JP, Eliasziw M; Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345(5):311-318.
8. Engel J Jr, Wiebe S, French J, et al; Quality Standards Subcommittee of the American Academy of Neurology; American Epilepsy Society; American Association of Neurological Surgeons. Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology. 2003;60(4):538-547. (Pubitemid 36246066)
9. Berg AT, Langfitt J, Shinnar S, et al. How long does it take for partial epilepsy to become intractable? Neurology. 2003;60(2):186-190.
10. Choi H, Carlino R, Heiman G, Hauser WA, Gilliam FG. Evaluation of duration of epilepsy prior to temporal lobe epilepsy surgery during the past two decades. Epilepsy Res. 2009;86(2-3):224-227.
11. Haneef Z, Stern J, Dewar S, Engel J Jr. Referral pattern for epilepsy surgery after evidence-based recommendations: a retrospective study. Neurology. 2010; 75(8):699-704.
12. Jacoby A, Baker GA, Steen N, Potts P, Chadwick DW. The clinical course of epilepsy and its psychosocial correlates: findings from a UK Community study. Epilepsia. 1996;37(2):148-161. (Pubitemid 26043793)
13. Jokeit H, Ebner A. Effects of chronic epilepsy on intellectual functions. Prog Brain Res. 2002;135:455-463. (Pubitemid 35461041)
14. Sperling MR. The consequences of uncontrolled epilepsy. CNS Spectr. 2004;9(2):98-101, 106-109.
15. Choi H, Sell RL, Lenert L, et al. Epilepsy surgery for pharmacoresistant temporal lobe epilepsy: a decision analysis. JAMA. 2008;300(21):2497-2505.
16. McClelland S III, Guo H, Okuyemi KS. Population-based analysis of morbidity and mortality following surgery for intractable temporal lobe epilepsy in the United States [published online February 14, 2011]. Arch Neurol. doi:10.1001/archneurol.2011.7. 2011;68(6):725-729.
17. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069-1077.